NCT05354583View on ClinicalTrials.gov

Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Mycobacterium Abscessus InfectionAdult-Onset Immunodeficiency With Acquired Anti-Interferon-Gamma AutoantibodiesNontuberculous Mycobacterial Pulmonary Infection
Interventions
DRUG

Appropriate treatment

Treatment with at least 3 antibiotics, which the pathogen is susceptible to based on in vitro drug susceptibility test, in the initial phase of the treatment

Trial Locations (1)

10330

King Chulalongkorn Memorial Hospital, Pathum Wan

All Listed Sponsors
lead

King Chulalongkorn Memorial Hospital

OTHER